| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.005 |